Our findings confirms a previous study by Peng et al. in breast cancer cell-lines, transfected with myristoylated AKT (Myr-AKT) isoforms via retroviral delivery system, where AKT isoforms uniformly decreased the frequency of CD44 subpopulations [64]. The gene discussed is AKT1; the disease is breast carcinoma.